Salivary Cortisol and Periodontitis Severity: A Cross-Sectional Biomarker-Based Assessment of Stress and Inflammation
Medical Sciences · 2025
DOI: 10.3390/medsci13030120 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Medical Sciences, 2025. Verfasst von Velitchka Dosseva-Panova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Faculty of Dental Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Hydrocortisone, Saliva, Periodontitis, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Ministry of Education and Science.
Abstract (Originalsprache)
Background
Psychological stress is increasingly recognized as a potential modifier of periodontal disease through both behavioral and biological mechanisms. Cortisol, a key stress hormone, exerts complex immunomodulatory effects and may influence periodontal inflammation and tissue breakdown. This study aimed to compare salivary levels of cortisol, interleukin-1β, and interleukin-6 in patients with varying periodontitis severity and examine their associations with clinical periodontal parameters.
Methods
A total of 67 patients diagnosed with periodontitis were classified according to the 2017 World Workshop Classification into Stage I/II vs. Stage III/IV and Grade B vs. Grade C. Unstimulated saliva samples were collected and analyzed for cortisol using electrochemiluminescence immunoassay, and for IL-1β and IL-6 using ELISA. Statistical analyses included Mann-Whitney U test, Spearman’s correlations, and multivariate regression.
Results
Median salivary cortisol levels were significantly higher in Stage III/IV (11.90 nmol/L) than in Stage I/II (7.64 nmol/L; p = 0.014) and in Grade C (10.60 nmol/L) vs. Grade B (7.70 nmol/L; p = 0.019). In multivariate analysis, cortisol independently predicted both Stage III/IV (OR = 1.23, p = 0.007) and Grade C (OR = 1.24, p = 0.026) periodontitis. ROC analysis showed that salivary cortisol had moderate diagnostic performance for Stage III/IV periodontitis (AUC = 0.68, cut-off 11.57 nmol/L) and Grade C (AUC = 0.67, cut-off 9.76 nmol/L). Cortisol showed significant positive correlations with clinical markers of disease severity and with IL-1β (r = 0.399, p = 0.001) and IL-6 (r = 0.424, p < 0.001).
Conclusions
Salivary cortisol is a promising non-invasive biomarker reflecting both stress-related physiological burden and clinical severity in periodontitis. Cortisol measurement may represent a valuable addition to multifactorial assessments and risk stratification in periodontitis, pending further validation in longitudinal studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Faculty of Dental Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria.
- Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University-Sofia, 1431 Sofia, Bulgaria.
ORCID-Profile: Velitchka Dosseva-Panova, Marina Miteva, Dimitar Dimitrov
Förderung
- Bulgarian Ministry of Education and Science
Zitieren
APA
Dosseva-Panova, V., Mlachkova, A., Miteva, M., & Dimitrov, D. (2025). Salivary Cortisol and Periodontitis Severity: A Cross-Sectional Biomarker-Based Assessment of Stress and Inflammation. Medical Sciences. https://doi.org/10.3390/medsci13030120
Vancouver
Dosseva-Panova V, Mlachkova A, Miteva M, Dimitrov D. Salivary Cortisol and Periodontitis Severity: A Cross-Sectional Biomarker-Based Assessment of Stress and Inflammation. Medical Sciences. 2025. doi:10.3390/medsci13030120
BibTeX
@article{DossevaPanova2025,
author = {Dosseva-Panova, Velitchka and Mlachkova, Antoaneta and Miteva, Marina and Dimitrov, Dimitar},
title = {Salivary Cortisol and Periodontitis Severity: A Cross-Sectional Biomarker-Based Assessment of Stress and Inflammation},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13030120}
}
EUVIMED